Table 1
Studies discussed in this paper
| Study acronym | Study name |
|---|---|
| ADMIRAL | Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long term follow-up |
| ADVANCE-MI | Addressing the value of facilitated angioplasty after combination treatment or eptifibatide monotherapy in acute myocardial infarction |
| ASSENT-4 | Fourth assessment of the safety and efficacy of a new thrombolytic |
| C-PORT | Atlantic cardiovascular patient outcomes research team |
| CADILLAC | Controlled abciximab and device investigation to lower late angioplasty complications |
| CAPTIM | Comparison of primary angioplasty and prehospital thrombolysis in the acute phase of myocardial infarction |
| DANAMI-2 | Danish multicentre randomized trial on thrombolytic treatment versus acute coronary angioplasty in acute myocardial infarction |
| FINESSE | Facilitated intervention with enhanced reperfusion speed to stop events |
| PCI-CURE | Percutaneous coronary intervention in the clopidogrel in unstable angina to prevent recurrent events |
| PRAGUE | Primary angioplasty in patients transferred from general community hospitals to specialized PTCA units with or without emergency thrombolysis |
| TIMI | Thrombolysis in myocardial infarction |
